HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Thromboembolism of pulmonary artery branches based on the registry data of Tomsk hospitals].

Abstract
The aim of this work was to study dynamics of new cases of hospital thromboembolism of pulmonary artery branches (TEPA) based on the registry data of Tomsk hospitals for 2003-2010 and to estimate applicability of recommendations of European Society of Cardiologists (2008) on diagnostics and treatment of TEPA. Case records and autopsy protocols were available for analysis. The data were treated using Statistica for Windows 6.0 package. 5.04% of the deceased patients had TEPA according to autopsy data. The discrepancy between clinical and pathoanatomical findings averaged 57.6%. In 2010, TEPA was not diagnosed in 35.6% patients. The number of new cases of submassive TEPA and TEPA of small branches with the fatal outcome decreased to 40.7 and 48% since 2007 while the incidence of lethal massive thromboembolism amounted to 68%. Its increase was especially notable among men after 2008. In 2003, 73.3% of the patients who died from TEPA were women while it was the cause of death in 54.8% of men in 2010. The duration of hospital stay was 0-16 (mean 8/1 +- 7.8) bed-days. Most patients (60.3%) had 3 or more risk factors. The frequency of TRPA relapses correlated with the presence of pericardial fluid (p = 0.039) and acute myocardial infarction (p = 0.023). In 24.2% of the cases. TEPA originated in heart chambers.
AuthorsO Ia Vasil'tseva, I N Vorozhtsova, A V Krestinin, R S Karpov
JournalKlinicheskaia meditsina (Klin Med (Mosk)) Vol. 91 Issue 3 Pg. 28-30 ( 2013) ISSN: 0023-2149 [Print] Russia (Federation)
PMID23789448 (Publication Type: English Abstract, Journal Article)
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Female
  • Hospitals (statistics & numerical data)
  • Humans
  • Incidence
  • Length of Stay
  • Male
  • Middle Aged
  • Pulmonary Artery (pathology)
  • Registries (statistics & numerical data)
  • Risk Factors
  • Russia (epidemiology)
  • Thromboembolism (epidemiology, etiology, mortality)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: